Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa

Overview of attention for article published in Frontiers in Pharmacology, October 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 11,376 followers.

New Research: Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa https://t.co/op1WBwTWZ8 #pharmacology

15 Oct 2022

Reply Repost Favourite

RT @SumaginLab: Check out our new paper on potential repurposing of anti-malarian drugs to treat IBD. Congrats to our talented postoc ⁦@Lau…

15 Oct 2022

Reply Repost Favourite

RT @SumaginLab: Check out our new paper on potential repurposing of anti-malarian drugs to treat IBD. Congrats to our talented postoc ⁦@Lau…

14 Oct 2022

Reply Repost Favourite

An interesting paper by the Sumagin lab. I wonder how many drugs out there could be repurposed for other diseases. Repurposing drugs could save time and money in safety trials, as one could piggy back on prior safety data

14 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.